Tvardi Therapeutics, Inc.
TVRD
Nasdaq
Manufacturing
Chemicals
€ 2,92
▼
€ 0,14
(-4,43%)
Marktkapitalisatie: 27,35 M
Prijs
€ 2,92
Marktkapitalisatie
27,35 M
Dagbereik
€ 2,86 — € 3,08
52-Weeksbereik
€ 2,75 — € 43,65
Volume
25.192
Openen € 2,98
50D / 200D Gem.
€ 3,73
21,79% below
50D / 200D Gem.
€ 14,25
79,54% below
Koershistorie
Financiële Trends
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 7,14 M | 20,97 M | 41,87 M | 23,03 M |
| Net Income | -18,21 M | -70,87 M | -118,51 M | -85,47 M | -88,44 M |
| EPS (Diluted) | -3,26 | -15,53 | -2,19 | -1,59 | -1,74 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -26,75 M | -58,38 M | -121,50 M | -87,54 M | -89,08 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 18,01 M | 32,81 M | 108,51 M | 91,88 M | 82,70 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 95.000,0 | 192.000,0 | 259.000,0 | 248.000,0 | 248.000,0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | -398.000,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32,07 M | 43,83 M | 125,84 M | 182,24 M | 247,06 M |
| Total Liabilities | 11,13 M | 48,42 M | 68,76 M | — | — |
| Shareholders' Equity | 20,95 M | -4,59 M | 57,09 M | 158,78 M | 227,52 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 20,73 M | 37,90 M | 51,78 M | 63,74 M | 13,45 M |
| Current Assets | 31,54 M | 43,83 M | 116,16 M | 168,91 M | 173,29 M |
| Current Liabilities | 11,04 M | 3,97 M | 25,59 M | 23,46 M | 17,62 M |
{"event":"ticker_viewed","properties":{"ticker":"TVRD","listing_kind":"stock","pathname":"/stocks/tvrd","exchange":"Nasdaq","country":"US"}}